Regenxbio Inc buy BiotechBee
Start price
08.09.24
/
60%
€10.30
Target price
28.02.27
€16.00
Performance (%)
-22.82%
End price
14.12.24
€7.95
Summary
This prediction ended on 14.12.24 with a price of €7.95. The prediction for Regenxbio Inc disappointed with a performance of -22.82%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regenxbio Inc | 10.219% | 10.219% | 19.841% |
| iShares Core DAX® | -0.383% | 2.613% | 11.343% |
| iShares Nasdaq 100 | -0.411% | -2.005% | 5.353% |
| iShares Nikkei 225® | 1.838% | 9.391% | 33.529% |
| iShares S&P 500 | -0.712% | -0.476% | 2.508% |
According to BiotechBee what are the pros and cons of Regenxbio Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Regenxbio Inc diskutieren
Buy mit Kursziel 16,0